Efficacy and safety of semaglutide compared with liraglutide and placebo for weight loss in patients with obesity: a randomised, double-blind, placebo and active controlled, dose-ranging, phase 2 trial - O’Neil, P M; Birkenfeld, A L; McGowan, B (Lancet, 2018)
et al.